Scopus BiopharmaSCPS
13F holders, Q4 2024 (December 31)1holders
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding Scopus Biopharma Inc. (SCPS) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 0 sold out. The largest holder was FSA Wealth Management LLC ($0).
- Company
- Scopus Biopharma Inc.
- CUSIP
- 809171101
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q4 2024: 100 shares bought, net +100 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| FSA Wealth Management LLC | 0.00% | New | 100 | $0 |
"% of holder's portfolio" is SCPS's weight in each manager's 13F, not the share of Scopus Biopharma Inc. the manager owns.